AVRO Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (20 jun 2024 @ 22:00):
Our systems believe the stock currently is undervalued by 1 097.51% compare to its pairs and should correct upwards.

AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide...

Stats
Dagens volum	204 382
Gjennomsnittsvolum	17 865
Markedsverdi	5.24M
EPS	$-0.150 ( Q1 \| 2024-05-09 )
Neste inntjeningsdato	( $-0.0800 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0.170 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0790 (0.47%)

AADI -5.88%

ABCL 0.92%

ABCM 0.04%

ABEO -3.08%

ABIO -0.30%

ABOS 2.10%

ABSI 3.40%

ABUS -0.98%

ABVX -3.00%

ACAD -0.22%

ACER -17.95%

ACET -9.18%

ACGN 1.29%

ACHL -1.70%

ACHV 1.93%

ACIU -0.50%

ACLX -0.37%

ACRV -4.29%

ACST -3.58%

ACXP 3.69%

ADAG 7.14%

ADAP -4.00%

ADGI 0.87%

ADIL -2.66%

ADMA -1.23%

ADPT 0.44%

ADTX -3.47%

ADVM 1.30%

ADXN -1.60%

AEON -4.67%

AEZS -2.49%

AFMD -3.15%

AGEN -4.00%

AGIO -2.35%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 8.24%

AKRO -2.26%

AKTX -5.23%

AKUS 0.00%

ALBO 0.00%

ALDX -2.25%

ALEC -0.80%

ALGS -0.38%

ALKS 1.99%

ALLK -11.06%

ALLO -2.29%

ALLR -1.63%

ALNA 3.16%

ALNY 2.37%

ALPN 0.02%

ALPX 0.00%

ALRN -2.63%

ALT -15.29%

ALVR -1.01%

ALXN 0.00%

ALXO -10.43%

ALZN 5.10%

AMRN -4.30%

AMTI -3.13%

ANAB 1.55%

ANEB 7.95%

ANGN 0.00%

ANIX -3.64%

ANL -0.14%

ANNX 3.93%

ANPC -3.15%

APGE 1.92%

APGN 8.48%

APGNW 30.65%

APLM -5.86%

APLS 0.40%

APLT 1.13%

APM 1.47%

APOP 0.38%

APRE -3.13%

APTO 0.62%

APTX 3.17%

APVO 3.30%

ARAV -13.39%

ARCT -6.62%

ARDS -12.13%

ARDX 2.16%

ARGX -0.78%

ARNA 0.00%

ARPO -0.90%

ARQT -3.28%

ARTL -2.50%

ARTLW 0.00%

ARVN 6.87%

ARWR -2.42%

ASLN -2.45%

ASMB -5.55%

ASND -2.25%

ATAI -3.69%

ATHA 7.76%

ATHE 0.08%

ATHX -33.50%

ATNF 2.18%

ATOS 5.34%

ATRA -6.27%

ATXI 1.09%

ATXS -0.33%

AUPH -0.81%

AURA 4.71%

AUTL -3.30%

AVBP -2.17%

AVEO 0.00%

AVIR -1.75%

AVRO -1.41%

AVTE -0.68%

AVTX -4.26%

AVXL -5.68%

AXLA 0.00%

AXSM -1.33%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.50%

BCAB -7.17%

BCDA -0.85%

BCDAW -46.41%

BCEL 0.00%

BCLI 3.09%

BCRX 1.73%

BCTX 13.26%

BCTXW 1.77%

BCYC 1.15%

BDRX -5.56%

BDTX 0.11%

BEAM 2.64%

BFRA -2.91%

BGNE -2.94%

BIOR -3.83%

BIVI 1.71%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -1.76%

BLTE -1.25%

BLU 0.03%

BLUE -4.84%

BMEA -15.26%

BMRN 0.20%

BNOX 4.46%

BNTC -2.39%

BNTX -2.11%

BOLD -11.17%

BOLT 0.33%

BPMC -2.17%

BPTH -4.05%

BPTS -13.47%

BRNS -0.37%

BRTX -5.90%

BTAI 13.08%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 2.78%

CABA 1.31%

CADL 1.42%

CALA 0.00%

CALC -3.82%

CALT -1.59%

CAPR -0.22%

CARA -12.09%

CARM 6.35%

CASI -1.18%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 1.22%

CCCC -1.49%

CCXI 0.00%

CDAK 0.00%

CDIO -4.66%

CDIOW 24.00%

CDMO -1.69%

CDMOP 0.04%

CDT -6.10%

CDTTW -39.60%

CDTX -6.36%

CDXC 9.84%

CDXS 9.48%

CELC -3.40%

CELU 0.74%

CELUW 11.80%

CERC -1.68%

CERE -1.42%

CERO -4.94%

CEROW -10.18%

CFRX -27.95%

CGEM 0.18%

CGEN -3.32%

CGON -2.62%

CGTX -3.43%

CHMA -6.00%

CHRS 4.76%

CINC 0.00%

CING -3.90%

CINGW 34.95%

CKPT -0.96%

CLBS -16.75%

CLDX -0.47%

CLGN -0.40%

CLLS -3.11%

CLNN -2.50%

CLNNW 0.00%

CLRB 6.47%

CLSD -3.20%

CLSN -0.68%

CLVS 0.00%

CMMB -2.94%

CMND 3.23%

CMPI 0.00%

CMPX 0.93%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.55%

CNCE 0.00%

CNSP -34.50%

CNST 0.00%

CNTA 0.79%

CNTB -1.50%

CNTX -7.76%

COCP -1.83%

COEPW 32.45%

COGT -2.76%

CORT 3.41%

COYA -2.42%

CPRX -1.25%

CRBP -1.69%

CRBU -7.95%

CRDF 2.21%

CRGX -1.81%

CRIS -2.64%

CRNX -5.89%

CRSP 1.07%

CRTX 2.63%

CRVO -4.50%

CRVS 0.00%

CSBR -0.19%

CTCX 1.20%

CTIC 0.06%

CTMX -3.31%

CTNM 4.72%

CTXR -4.51%

CUE -2.42%

CVAC -5.08%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 21.50%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.74%

CYTO 0.00%

DARE 0.86%

DAWN -0.15%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 31.86%

DNLI -1.88%

DNTH -2.52%

DOMH 1.06%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW 0.00%

DRUG -0.10%

DSGN -2.42%

DTIL -0.21%

DYAI 9.68%

EARS -1.77%

EDIT -2.92%

EDSA 4.14%

EFTR 1.50%

EFTRW -51.85%

EIGR -9.21%

ELAB -3.01%

ELDN 7.17%

ELEV -1.45%

ELOX 10.77%

ELTX -3.38%

ELVN -1.35%

ELYM 5.44%

ENGN 0.49%

ENGNW -21.67%

ENLV -1.45%

ENOB 1.79%

ENSC 6.55%

ENTA -0.90%

ENTO -4.97%

ENTX 0.53%

ENVB -0.02%

EPIX -2.68%

EPRX -2.87%

EPZM 0.00%

EQ -1.24%

EQRX -2.09%

EQRXW 0.00%

ERAS 6.25%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -6.04%

ETON 2.59%

ETTX 0.00%

EVAX 0.00%

EVGN 3.46%

EVLO 0.00%

EWTX 0.23%

EXAI -0.38%

EXEL 0.94%

EYEG -0.69%

EYEN 0.00%

EYPT 0.00%

FATE -12.23%

FBIO 0.90%

FBIOP 0.87%

FBLG -10.30%

FBRX -0.04%

FDMT -4.68%

FENC -2.74%

FGEN -9.83%

FHTX 8.59%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.67%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.69%

FULC 2.34%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -0.45%

GANX -1.54%

GBIO -1.06%

GBT 0.01%

GDTC 1.01%

GERN -1.44%

GHRS -4.27%

GLMD -2.48%

GLPG -1.79%

GLSI 9.27%

GLTO -3.90%

GLUE -2.37%

GLYC -15.09%

GMAB -0.33%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.34%

GNLX -3.98%

GNPX -4.41%

GNTA 3.94%

GOSS -7.72%

GOVX -5.91%

GOVXW 10.89%

GPCR -5.88%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -2.17%

GRTX -1.66%

GTHX 2.27%

GUTS 0.00%

GXGXW 41.67%

GYRE -5.95%

HALO -0.94%

HARP 0.09%

HCWB -4.01%

HEPA -3.50%

HGEN -84.62%

HILS 5.66%

HLVX -0.08%

HOOK 1.41%

HOTH -3.67%

HOWL 0.43%

HRMY 3.30%

HRTX 8.36%

HSTO 0.00%

HUMA 1.93%

HUMAW -6.25%

IBRX -5.98%

ICCC -2.10%

ICPT 0.21%

ICU 18.68%

ICUCW 4.86%

ICVX -0.91%

IDRA -23.04%

IDYA -3.09%

IFRX -3.10%

IGMS -2.12%

IKNA -1.49%

IKT -2.08%

IMAB -0.58%

IMCR -3.27%

IMGN 0.02%

IMGO 0.00%

IMMP 5.51%

IMMX -4.80%

IMNM 3.73%

IMNN 1.77%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.84%

IMTX -1.17%

IMTXW 6.00%

IMUX -3.74%

IMV 0.00%

IMVT -3.77%

INAB -1.12%

INBX -3.05%

INCY -2.08%

INDP 6.88%

INFI -52.38%

INKT 0.00%

INM 3.06%

INMB 1.12%

INO 2.02%

INSM -0.82%

INTS -3.73%

INVA 0.74%

INZY 1.14%

IOBT -7.09%

IONS 1.74%

IOVA -4.02%

IPA 0.03%

IPHA 2.54%

IPSC -2.34%

IRON -1.82%

ISEE 0.38%

ITOS 2.87%

ITRM 1.36%

IVA 6.96%

IVVD 0.41%

JAGX 0.70%

JANX -5.14%

JAZZ -0.81%

JNCE 0.00%

JSPR -1.51%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.46%

KALV -2.47%

KDNY 0.22%

KMPH -0.34%

KNSA -2.42%

KNTE -0.38%

KOD -9.07%

KPRX -5.76%

KPTI -8.85%

KRBP -10.00%

KRON 1.61%

KROS -0.33%

KRRO -1.59%

KRTX 0.03%

KRYS 0.99%

KTRA 10.02%

KTTA -0.65%

KTTAW 0.92%

KURA 0.98%

KYMR -3.44%

KYTX -5.56%

KZIA 6.13%

KZR -1.77%

LABP 0.57%

LBPH 0.63%

LBPS 0.00%

LBPSW 14.81%

LEGN 3.17%

LENZ -3.21%

LEXX 0.58%

LEXXW -14.63%

LGND -0.82%

LGNDV 0.00%

LGVN -9.04%

LIAN -8.28%

LIFE 2.70%

LIPO -5.29%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.43%

LPCN -4.36%

LPTX -1.10%

LQDA 0.37%

LRMR -0.36%

LSTA -1.68%

LTRN 5.49%

LUMO 0.67%

LVTX -4.12%

LXEO -13.57%

LXRX -0.59%

LYEL -36.03%

LYRA 4.22%

MACK 0.10%

MBIO -11.91%

MBRX -1.43%

MCRB 1.01%

MDGL -1.81%

MDNA -13.16%

MDWD 3.36%

MDXG -1.69%

MEIP 0.70%

MESO -1.48%

MGNX -5.24%

MGTA -7.74%

MGTX -0.83%

MGX -0.54%

MIRM -0.63%

MIRO 0.59%

MIST 1.92%

MITO 0.00%

MLEC -6.54%

MLECW 2.31%

MLND -5.36%

MLTX 0.76%

MLYS -8.38%

MNKD -0.57%

MNMD 2.83%

MNOV 1.41%

MNPR -9.34%

MOLN 0.76%

MOR 0.62%

MORF -2.89%

MREO 0.00%

MRKR -0.43%

MRNA -10.67%

MRNS -6.25%

MRSN -3.57%

MRTX -0.17%

MRUS 0.70%

MRVI 1.31%

MTCR -1.29%

MTEM 7.43%

MTP -18.50%

MURA -4.02%

MYMD 1.08%

NAMS 0.08%

NAMSW 0.64%

NAUT 0.67%

NBRV 0.71%

NBSE -1.56%

NBTX 8.91%

NCNA -0.18%

NERV -0.32%

NEXI 1.50%

NGM -1.28%

NGNE 3.89%

NKGN 10.92%

NKGNW -20.00%

NKTR 1.87%

NKTX -2.77%

NLSP 4.91%

NLSPW 26.67%

NMRA -1.26%

NMTR -42.97%

NOVN -24.84%

NRBO 14.85%

NRIX -1.47%

NRSN 0.78%

NRSNW 0.00%

NRXP -8.92%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.63%

NTEC -12.45%

NTHI 0.00%

NTLA -4.63%

NTRBW -31.07%

NUVL -1.83%

NVAX -5.64%

NVCT -8.58%

NVIV -34.28%

NXTC -5.88%

NYMX -0.05%

OABI 3.03%

OABIW -10.06%

OBIO 0.00%

OBSV 0.00%

OCEA -4.23%

OCGN 7.66%

OCS -1.00%

OCUL 0.23%

OCUP 0.00%

ODT -4.27%

OKYO 1.72%

OLMA -4.52%

OMER -2.57%

OMGA -2.08%

ONCO 6.16%

ONCR -3.08%

ONCS 31.87%

ONCT -2.04%

ONCY 2.90%

ONTX -0.47%

ONVO 2.00%

OPNT 0.00%

OPT -5.15%

ORGS -0.69%

ORIC -3.56%

ORMP 16.29%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -0.14%

OVID 0.40%

OYST 0.00%

PALI -0.48%

PASG 0.00%

PBLA -7.50%

PBM -4.75%

PBYI 4.56%

PCSA 0.00%

PCVX 0.64%

PDSB -5.09%

PEPG 1.31%

PGEN -6.59%

PHAR 1.99%

PHAS 0.00%

PHAT 0.39%

PHIO -3.55%

PHIOW 36.47%

PHVS -6.50%

PHXM -5.20%

PIRS 0.11%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -2.56%

PLUR 10.34%

PMN -5.55%

PMVP -1.19%

PNT 0.16%

PPBT -3.19%

PRAX 4.97%

PRDS 0.93%

PRLD -3.43%

PROG -3.47%

PROK 2.24%

PRQR 1.20%

PRTA -3.30%

PRTC 0.49%

PRTG 1.40%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -12.20%

PSTX -4.26%

PTCT 0.01%

PTE -0.82%

PTGX 1.12%

PTIXW -48.41%

PULM 1.56%

PXMD 4.76%

PYPD 1.71%

PYXS 4.58%

QLGN -5.84%

QNCX 2.23%

QNRX 0.84%

QSI -28.69%

QSIAW -9.44%

QTTB 3.65%

QURE -1.35%

RAIN -1.63%

RANI 4.28%

RAPT -1.79%

RARE 1.86%

RCKT -10.29%

REGN -0.16%

RENB -3.42%

REPL -2.61%

RETA 0.02%

REUN -0.89%

REVB -1.86%

REVBU 3.46%

REVBW 5.00%

RGLS -5.61%

RGNX -6.41%

RIGL -6.24%

RLAY -5.64%

RLMD -0.33%

RLYB -5.37%

RNA 2.29%

RNAC -0.42%

RNAZ -1.92%

RNXT 2.23%

ROIV -2.17%

ROIVW 4.56%

RPHM -2.48%

RPRX -0.76%

RPTX -1.17%

RUBY 2.70%

RVLP -32.05%

RVMD -0.35%

RVMDW -29.90%

RVNC -0.43%

RVPH -0.40%

RVPHW -5.28%

RXDX 0.09%

RXRX -5.97%

RYTM -5.82%

RYZB 0.02%

RZLT 3.10%

SABS -1.37%

SABSW -5.53%

SAGE -0.37%

SANA -2.12%

SAVA -4.41%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 1.29%

SCPH 11.62%

SCPS 0.00%

SEEL -3.18%

SEER 0.29%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -5.62%

SGMT -5.06%

SGTX -2.56%

SIOX 22.63%

SLDB -2.33%

SLGL 5.23%

SLN -8.77%

SLNO 0.58%

SLRX 0.40%

SLS -3.85%

SMMT -3.50%

SNDX 2.15%

SNGX 3.40%

SNPX -2.77%

SONN -1.59%

SPPI -0.49%

SPRB -1.68%

SPRC -3.29%

SPRO 0.38%

SRNE 0.00%

SRPT -0.66%

SRRA 0.00%

SRRK -1.24%

SRZN -2.45%

STAB 0.00%

STOK -6.88%

STRO -1.84%

STSA 0.00%

STTK 7.03%

SURF -0.93%

SVRA -4.08%

SWTX 0.19%

SYBX 0.00%

SYRS -2.07%

TALS -0.73%

TARA -7.62%

TARS -2.48%

TBPH 0.18%

TCBP 5.49%

TCDA 0.00%

TCON -0.70%

TCRR 0.00%

TCRT 4.48%

TCRX -2.27%

TECH -1.25%

TENX -0.32%

TERN -6.48%

TFFP -11.17%

TGTX -7.99%

THRX 0.12%

TIL -1.22%

TLC 0.00%

TLSA -4.65%

TNGX -3.67%

TNXP -9.61%

TNYA -6.48%

TPST 5.35%

TRDA -4.71%

TRVI 1.92%

TRVN 3.15%

TSHA -17.04%

TSVT -4.12%

TTNP -6.05%

TVTX 3.83%

TYRA -7.50%

UBX -2.73%

UNCY -4.00%

URGN 3.85%

UTHR -0.42%

VACC 11.36%

VALN -3.15%

VAXX 118.75%

VBIV -0.79%

VBLT -8.77%

VCEL 1.65%

VCNX 9.30%

VCYT -0.95%

VERA -4.48%

VERU 1.59%

VERV -3.54%

VIGL 1.07%

VINC 2.81%

VIR -1.14%

VIRI -5.66%

VIRX 3.47%

VKTX -1.15%

VLON -13.04%

VNDA -2.93%

VOR -6.43%

VRCA 1.42%

VRDN -3.37%

VRNA -1.99%

VRPX 3.58%

VRTX -0.09%

VSTM 4.93%

VTGN -2.26%

VTVT 1.28%

VTYX -1.68%

VXRT -0.39%

VYGR -0.64%

VYNE -5.80%

VYNT 7.78%

WINT -2.72%

WVE -8.07%

XBIO 1.03%

XBIT 4.17%

XCUR 0.23%

XENE -0.92%

XERS 5.00%

XFOR 5.76%

XLO 3.06%

XLRN 0.00%

XNCR 0.28%

XOMA -7.04%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.72%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.70%

ZNTL -1.07%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-05-14	Leonard Braden Michael	Buy	296 882	Common Stock
2024-05-13	Leonard Braden Michael	Buy	216 053	Common Stock
2024-05-13	Leonard Braden Michael	Buy	253 700	Common Stock
2024-05-13	Leonard Braden Michael	Sell	0	Common Stock
2024-05-13	Leonard Braden Michael	Buy	0	Common Stock

INSIDER POWER
71.30
Last 99 transactions
Buy: 6 444 125 \| Sell: 1 294 974

Korrelasjon (AI algo v.1.1b): Undervalued: 1 097.51% $202.62 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Volum Korrelasjon

Lang: -0.71 (moderate negative)

Kort: 0.60 (weak)

Signal:(58.167) Neutral

AVROBIO Inc Korrelasjon

10 Mest positive korrelasjoner
LFUS	0.847
QCLN	0.829
VMAR	0.825
ALTM	0.825
BNGO	0.824
KOSS	0.821
YORW	0.82
UXIN	0.819
OM	0.816
LDTC	0.814

10 Mest negative korrelasjoner
OZEM	-1
ERNZ	-0.902
INDH	-0.86
BKHAR	-0.853
BKHA	-0.832
AGMI	-0.809

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

AVROBIO Inc Korrelasjon - Valuta/Råvare

-0.18
( neutral )

-0.31
( neutral )

-0.34
( neutral )

-0.48
( neutral )

-0.36
( neutral )

-0.23
( neutral )

AVROBIO Inc Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-617 000 (0.00 %)
EPS:	$0.270

FY	2023
Omsetning:	$0
Bruttogevinst:	$-617 000 (0.00 %)
EPS:	$0.270

FY	2022
Omsetning:	$0
Bruttogevinst:	$-4.17M (0.00 %)
EPS:	$-2.42

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-2.78

Financial Reports:

No articles found.

AVROBIO Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

AVROBIO Inc

AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's product includes AVR-RD-01, a gene therapy for the treatment of Fabry disease. It is also developing AVR-RD-02, which is in phase 1/2 clinical trial for the treatment of type 1 Gaucher disease; AVR-RD-03, for the treatment of Pompe disease; AVR-RD-04 for the treatment of cystinosis; AVR-RD-05 for the treatment of Hunter syndrome; and AVR-RD-06 that is in preclinical stage for the treatment of Gaucher disease type 3. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.